In Vitro Evaluation of N -Formimidoyl Thienamycin (MK0787) Combined with Amikacin Against Gram-Negative Bacilli and Staphylococcus aureus
- 1 December 1982
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 22 (6), 1064-1066
- https://doi.org/10.1128/aac.22.6.1064
Abstract
The in vitro synergistic activity of N -formimidoyl thienamycin and amikacin was determined against gentamicin-resistant enterobacteriaceae, Pseudomonas aeruginosa , and Staphylococcus aureus. N -Formimidoyl thienamycin showed synergism with amikacin against 19 of the gentamicin-resistant strains, 14 of the 49 strains of S. aureus , and only 1 strain of the 46 P. aeruginosa isolates.Keywords
This publication has 11 references indexed in Scilit:
- Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stabilityAntimicrobial Agents and Chemotherapy, 1982
- Effect of N-formimidoyl thienamycin (MK0787) on beta-lactamases and activity against beta-lactamase-producing strainsAntimicrobial Agents and Chemotherapy, 1980
- In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycinAntimicrobial Agents and Chemotherapy, 1980
- In vitro activity of N-formimidoyl thienamycin (MK0787)Antimicrobial Agents and Chemotherapy, 1980
- MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activitiesAntimicrobial Agents and Chemotherapy, 1980
- Comparison of Techniques for Measurement of in Vitro Antibiotic SynergismThe Journal of Infectious Diseases, 1979
- Thienamycin, a new .BETA.-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.The Journal of Antibiotics, 1979
- Antibiotic combinations: the clinical relevance of synergy and antagonism.1978
- Binding of Thienamycin and Clavulanic Acid to the Penicillin-Binding Proteins of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1977
- Novel Method for Detection of β-Lactamases by Using a Chromogenic Cephalosporin SubstrateAntimicrobial Agents and Chemotherapy, 1972